A detailed history of Lester Murray Antman Dba Simply Rich transactions in Amgen Inc stock. As of the latest transaction made, Lester Murray Antman Dba Simply Rich holds 9,095 shares of AMGN stock, worth $2.87 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
9,095
Previous 9,095 -0.0%
Holding current value
$2.87 Million
Previous $2.84 Million 3.13%
% of portfolio
0.82%
Previous 0.9%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$262.75 - $319.31 $20,494 - $24,906
-78 Reduced 0.85%
9,095 $2.84 Million
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $1,754 - $1,940
-8 Reduced 0.09%
9,173 $2.22 Million
Q4 2021

Jan 07, 2022

BUY
$198.88 - $227.6 $1,591 - $1,820
8 Added 0.09%
9,181 $2.07 Million
Q3 2021

Oct 04, 2021

SELL
$212.27 - $248.7 $21,863 - $25,616
-103 Reduced 1.11%
9,173 $1.95 Million
Q2 2021

Jul 09, 2021

SELL
$233.58 - $259.14 $24,292 - $26,950
-104 Reduced 1.11%
9,276 $2.26 Million
Q4 2020

Feb 01, 2021

SELL
$216.38 - $257.67 $51,931 - $61,840
-240 Reduced 2.49%
9,380 $2.16 Million
Q3 2020

Nov 03, 2020

BUY
$234.65 - $260.95 $56,316 - $62,628
240 Added 2.56%
9,620 $2.45 Million
Q1 2020

May 06, 2020

SELL
$182.24 - $241.7 $37,541 - $49,790
-206 Reduced 2.15%
9,380 $1.96 Million
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $4,730 - $6,080
-25 Reduced 0.26%
9,586 $2.3 Million
Q2 2019

Aug 05, 2019

BUY
$166.7 - $195.41 $1.6 Million - $1.88 Million
9,611 New
9,611 $1.77 Million
Q4 2018

Feb 07, 2019

SELL
$178.4 - $208.25 $1.71 Million - $2 Million
-9,611 Closed
0 $0
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $4,151 - $4,662
-25 Reduced 0.26%
9,611 $1.77 Million
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $1.63 Million - $1.82 Million
9,636
9,636 $1.68 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lester Murray Antman Dba Simply Rich Portfolio

Follow Lester Murray Antman Dba Simply Rich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lester Murray Antman Dba Simply Rich, based on Form 13F filings with the SEC.

News

Stay updated on Lester Murray Antman Dba Simply Rich with notifications on news.